within Pharmacolibrary.Drugs.ATC.A;

model A11HA02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.6,
    Cl             = 2.0,
    adminDuration  = 600,
    adminMass      = 0.05,
    adminCount     = 1,
    Vd             = 0.00102,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 900
  );

  annotation(Documentation(
    info ="<html><body><p>Pyridoxine (vitamin B6) is a water-soluble vitamin required for amino acid, glucose, and lipid metabolism. It is used as a nutritional supplement, for deficiency states, and in the treatment of certain conditions such as pyridoxine-dependent epilepsy and to prevent isoniazid-induced neuropathy. Pyridoxine is approved and widely used today as a vitamin supplement.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers, both sexes; single oral administration.</p><h4>References</h4><ol><li>Brian J Wolk, Michael Ganetsky, Kavita M Babu,Toxicity of energy drinks.,Current opinion in pediatrics,2012<a href='https://pubmed.ncbi.nlm.nih.gov/22426157/'>https://pubmed.ncbi.nlm.nih.gov/22426157/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A11HA02;
